An ultrasonically powered implantable device for targeted drug delivery

Area of Science:

• Biomedical Engineering
• Materials Science
• Nanotechnology

Background:

• Current drug delivery systems face challenges in precise localization and programmability.
• Wireless power transfer in implantable devices is an area of active research for improved patient outcomes.
• Electroresponsive polymers offer potential for controlled drug release mechanisms.

Purpose of the Study:

• To develop and demonstrate a wirelessly powered implantable device for programmable, localized drug delivery.
• To investigate the use of ultrasonic power transfer for safe and efficient operation of the implant.
• To validate a design methodology for the implant electronics and drug release prediction.

Main Methods:

• Design and fabrication of a miniaturized implantable device (3 mm × 5 mm active area).
• Utilizing an external ultrasonic transmitter for wireless power, operating below 5% of FDA diagnostic limits.
• Employing drug-loaded polypyrrole nanoparticles stimulated electrically for drug release.
• Experimental validation of the implant electronics design and drug concentration prediction.

Main Results:

• Successful demonstration of a wirelessly powered implantable drug delivery system.
• Achieved drug release through electrical stimulation of polypyrrole nanoparticles.
• Validated design methodology accurately predicts released drug concentrations.
• The device operates at a safe ultrasonic power level.

Conclusions:

• This work presents the first ultrasonically powered implantable device for targeted drug delivery using electroresponsive polymers.
• The developed platform offers a safe, programmable, and localized approach to drug administration.
• The miniaturized electronics and validated design methodology pave the way for future therapeutic innovations.